Related Experiment Videos
Delayed functional loss in glaucoma. LII Edward Jackson Memorial Lecture
1Department of Ophthalmology, Mayo Clinic and Mayo Foundation, Rochester, MN 55905, USA.
American Journal of Ophthalmology
|May 1, 1996
Summary
Some glaucoma patients experience vision loss even after normal intraocular pressure. Four hypotheses explore causes, including pressure-independent processes or cell hypersensitivity, suggesting potential new treatments targeting apoptosis.
Area of Science:
- Ophthalmology
- Neuroscience
Background:
- Glaucoma is characterized by elevated intraocular pressure (IOP) and progressive visual field loss.
- Therapeutic normalization of IOP is the primary treatment strategy for glaucoma.
Observation:
- This study examines three glaucoma cases with normalized IOP but continued visual field deficits.
- These cases highlight a discrepancy between IOP control and functional vision preservation.
Findings:
- Four hypotheses are proposed: 1) IOP-independent ganglion cell death, 2) undetected IOP spikes, 3) genetically determined ganglion cell hypersensitivity to IOP, and 4) prior IOP damage rendering cells hypersensitive.
- Apoptosis is hypothesized as a potential final common pathway for ganglion cell death.
Implications:
- Current understanding cannot exclude any proposed hypotheses for persistent visual field loss.
- Inhibiting the apoptotic pathway presents a novel therapeutic target for glaucoma treatment.